(Updated - November 2, 2023 8:55 AM EDT)

Deutsche Bank analyst Emmanuel Papadakis downgraded Moderna (NASDAQ: MRNA) from Hold ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Downgrades Hot Comments Hot Downgrades

Moderna (MRNA) downside has played out, HSBC raises ratingNovember 3, 2023 9:49 AM Starbucks, DoorDash, Roku, Qualcomm rise premarket; Peloton, Moderna fallNovember 2, 2023 7:52 AM Moderna (MRNA) drops after announcing a $3.1 billion charge, partially due to Covid writedownsNovember 2, 2023 6:58 AM Moderna reins in 2023 COVID vaccine forecast, shares tumbleNovember 2, 2023 6:47 AM Moderna (MRNA) Reports Wide Q3 Loss on $3.1B Charge, as Revenues BeatNovember 2, 2023 6:36 AM Form 8-K Moderna, Inc. For: Nov 02November 2, 2023 6:34 AM Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates November 2, 2023 6:32 AM Moderna (MRNA) November weekly 76 straddle into quarter resultsNovember 2, 2023 4:51 AM Form 144 Moderna, Inc. Filed by: AFEYAN NOUBARNovember 1, 2023 4:04 PM Moderna (MRNA) call put ratio 1 call to put into quarter results and outlookNovember 1, 2023 10:31 AM Flagship Pioneering Launches Pioneering IntelligenceNovember 1, 2023 10:30 AM Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts sayNovember 1, 2023 6:20 AM